Fludara and Follicle centre lymphoma, follicular grade i, ii, iii recurrent - a phase IV clinical study of FDA data

Summary:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent is reported only by a few people who take Fludara.

The phase IV clinical study analyzes which people take Fludara and have Follicle centre lymphoma, follicular grade i, ii, iii recurrent. It is created by eHealthMe based on reports of 40,025 people who have side effects while taking Fludara from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

40,025 people reported to have side effects when taking Fludara.
Among them, 2 people (0.0%) have Follicle centre lymphoma, follicular grade i, ii, iii recurrent.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 40,042 Fludara users for its effectiveness, alternative drugs and more.

What is Follicle centre lymphoma, follicular grade i, ii, iii recurrent?

Follicle centre lymphoma, follicular grade i, ii, iii recurrent is found to be associated with 22 drugs and 25 conditions by eHealthMe.

Number of Fludara and Follicle centre lymphoma, follicular grade i, ii, iii recurrent reports submitted per year:

Could Fludara cause Follicle centre lymphoma, follicular grade i, ii, iii recurrent?

Gender of people who have Follicle centre lymphoma, follicular grade i, ii, iii recurrent when taking Fludara *:

female: 0.0 %
male: 100 %

Age of people who have Follicle centre lymphoma, follicular grade i, ii, iii recurrent when taking Fludara *:

Common drugs people take besides Fludara *:

Cytarabine: 2 people, 100.00%
Cyclosporine: 2 people, 100.00%
Cyclophosphamide: 2 people, 100.00%
Acyclovir: 2 people, 100.00%

Common side effects people have besides Follicle centre lymphoma, follicular grade i, ii, iii recurrent *:

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 100.00%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 100.00%

Common conditions people have *:

Bone Marrow Conditioning Regimen: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Follicle centre lymphoma, follicular grade i, ii, iii recurrent?

Check whether Follicle centre lymphoma, follicular grade i, ii, iii recurrent is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Follicle centre lymphoma, follicular grade i, ii, iii recurrent and when was it recovered:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent in Fludara

Expand to all the drugs that have ingredients of fludarabine phosphate:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent and drugs with ingredients of fludarabine phosphate

Alternative drugs to, pros and cons of Fludara:

Fludara (40,042 reports)

Common Fludara side effects:

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Follicle centre lymphoma, follicular grade i, ii, iii recurrent treatments and more:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent (47 reports)

COVID vaccines that are related to Follicle centre lymphoma, follicular grade i, ii, iii recurrent:

All the drugs that are associated with Follicle centre lymphoma, follicular grade i, ii, iii recurrent:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent (22 drugs)

All the conditions that are associated with Follicle centre lymphoma, follicular grade i, ii, iii recurrent:

Follicle centre lymphoma, follicular grade i, ii, iii recurrent (25 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.